Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Varga

Showing results (81-90 of 297) with videos related to

Pageof 30
Sort By:
Current Opinion in Rheumatology|September 17, 2020
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritisThais Ribeiro Peclat, Bo Shi, John Varga, et al.
Rheumatology (Oxford, England)|February 7, 2017
Right ventricular cardiomyopathy in systemic sclerosisRashad J Belin, John Varga, Jeremy D Collins, et al.
The Lancet. Rheumatology|September 27, 2024
Challenges and solutions for cellular therapy development in autoimmune diseasesElizabeth R Volkmann, John Varga, Bruce R Blazar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
A new transthyretin variant Leu55Gln in a patient with systemic amyloidosisMasahide Yazaki, John Varga, P James B Dyck, et al.
Rheumatology (Oxford, England)|June 7, 2021
Extensive soft tissue xanthomatosis masquerading as tophaceous gout in a normolipidemic manMichael Putman, Nathan Kong, Jon Lomasney, et al.
The Journal of Investigative Dermatology|July 4, 2003
Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of sclerodermaShinsuke Takagawa, Gabriella Lakos, Yasuji Mori, et al.
Current Rheumatology Reports|May 23, 2019
The Primary Cilium: Emerging Role as a Key Player in FibrosisMaria E Teves, Jerome F Strauss, Paulene Sapao, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|April 23, 2011
Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapySwati Bhattacharyya, Minghua Wu, Feng Fang, et al.
ACR Open Rheumatology|November 21, 2025
Cellular Therapy for Systemic Autoimmune Diseases: New Opportunities for Future Research and Interdisciplinary CollaborationElizabeth R Volkmann, Sencer Goklemez, John Varga, et al.
Arthritis Research & Therapy|July 13, 2018
Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin FibrosisBenjamin Korman, Roberta Goncalves Marangoni, Gabriel Lord, et al.
Pageof 30

Showing results (81-90 of 297) with videos related to

Sort By:
Pageof 30
Current Opinion in Rheumatology|September 17, 2020
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritisThais Ribeiro Peclat, Bo Shi, John Varga, et al.
Rheumatology (Oxford, England)|February 7, 2017
Right ventricular cardiomyopathy in systemic sclerosisRashad J Belin, John Varga, Jeremy D Collins, et al.
The Lancet. Rheumatology|September 27, 2024
Challenges and solutions for cellular therapy development in autoimmune diseasesElizabeth R Volkmann, John Varga, Bruce R Blazar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
A new transthyretin variant Leu55Gln in a patient with systemic amyloidosisMasahide Yazaki, John Varga, P James B Dyck, et al.
Rheumatology (Oxford, England)|June 7, 2021
Extensive soft tissue xanthomatosis masquerading as tophaceous gout in a normolipidemic manMichael Putman, Nathan Kong, Jon Lomasney, et al.
The Journal of Investigative Dermatology|July 4, 2003
Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of sclerodermaShinsuke Takagawa, Gabriella Lakos, Yasuji Mori, et al.
Current Rheumatology Reports|May 23, 2019
The Primary Cilium: Emerging Role as a Key Player in FibrosisMaria E Teves, Jerome F Strauss, Paulene Sapao, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|April 23, 2011
Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapySwati Bhattacharyya, Minghua Wu, Feng Fang, et al.
ACR Open Rheumatology|November 21, 2025
Cellular Therapy for Systemic Autoimmune Diseases: New Opportunities for Future Research and Interdisciplinary CollaborationElizabeth R Volkmann, Sencer Goklemez, John Varga, et al.
Arthritis Research & Therapy|July 13, 2018
Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin FibrosisBenjamin Korman, Roberta Goncalves Marangoni, Gabriel Lord, et al.
Pageof 30